Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$135.39
+2.0%
$119.23
$108.35
$160.27
$37.48B1.262.56 million shs2.31 million shs
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
$6.04
+0.5%
$5.88
$3.75
$9.40
$27.11M1.5327,944 shs16,552 shs
Defiance Daily Target 2X Long LMND ETF stock logo
LMNX
Defiance Daily Target 2X Long LMND ETF
$11.47
+2.4%
$15.04
$10.17
$55.00
$3.79M-11.0744,635 shs32,036 shs
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$493.91
+5.2%
$479.96
$385.46
$643.99
$174.52B0.882.41 million shs2.79 million shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
+1.89%+0.27%+17.21%+17.29%+15.94%
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
+0.50%-6.50%-12.34%+19.11%+8.19%
Defiance Daily Target 2X Long LMND ETF stock logo
LMNX
Defiance Daily Target 2X Long LMND ETF
+0.70%-18.94%-9.61%-23.54%-68.99%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
+5.22%+2.77%+6.30%-0.42%+20.89%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$135.39
+2.0%
$119.23
$108.35
$160.27
$37.48B1.262.56 million shs2.31 million shs
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
$6.04
+0.5%
$5.88
$3.75
$9.40
$27.11M1.5327,944 shs16,552 shs
Defiance Daily Target 2X Long LMND ETF stock logo
LMNX
Defiance Daily Target 2X Long LMND ETF
$11.47
+2.4%
$15.04
$10.17
$55.00
$3.79M-11.0744,635 shs32,036 shs
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$493.91
+5.2%
$479.96
$385.46
$643.99
$174.52B0.882.41 million shs2.79 million shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
+1.89%+0.27%+17.21%+17.29%+15.94%
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
+0.50%-6.50%-12.34%+19.11%+8.19%
Defiance Daily Target 2X Long LMND ETF stock logo
LMNX
Defiance Daily Target 2X Long LMND ETF
+0.70%-18.94%-9.61%-23.54%-68.99%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
+5.22%+2.77%+6.30%-0.42%+20.89%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
2.94
Moderate Buy$161.7119.44% Upside
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
2.00
Hold$6.00-0.66% Downside
Defiance Daily Target 2X Long LMND ETF stock logo
LMNX
Defiance Daily Target 2X Long LMND ETF
0.00
N/AN/AN/A
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
2.92
Moderate Buy$613.6724.25% Upside

Current Analyst Ratings Breakdown

Latest HBIO, LMNX, TMO, and A Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/3/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
DowngradeBuyHold$670.00 ➝ $540.00
6/3/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
DowngradeBuyHold$670.00 ➝ $540.00
6/3/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Lower Price TargetBuy$180.00 ➝ $165.00
6/2/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
UpgradeHold (C-)Hold (C)
6/2/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Reiterated RatingHold
6/2/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Initiated CoverageOutperform$535.00
6/1/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
UpgradeStrong-Buy
5/28/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Boost Price TargetBuy$147.00 ➝ $155.00
5/28/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Boost Price TargetOverweight$140.00 ➝ $145.00
5/28/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Lower Price TargetOverweight$165.00 ➝ $160.00
5/28/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
UpgradeNeutralBuy$150.00 ➝ $145.00
(Data available from 6/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$6.95B5.50$6.77 per share20.01$25.22 per share5.37
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
$86.55M0.31$11.84 per share0.51$3.07 per share1.97
Defiance Daily Target 2X Long LMND ETF stock logo
LMNX
Defiance Daily Target 2X Long LMND ETF
$437.66M0.01$0.35 per share32.98$11.13 per share1.03
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$44.56B4.12$31.97 per share15.45$142.17 per share3.47
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.30B$4.9827.1920.612.3619.55%24.33%12.99%8/26/2026 (Estimated)
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
-$56.70M-$2.17N/AN/AN/A-11.44%-25.78%-4.37%8/10/2026 (Estimated)
Defiance Daily Target 2X Long LMND ETF stock logo
LMNX
Defiance Daily Target 2X Long LMND ETF
$15.17M$0.5122.499.56N/A5.39%4.66%2.91%N/A
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$6.70B$18.1927.1518.102.0815.15%16.86%8.15%7/22/2026 (Estimated)

Latest HBIO, LMNX, TMO, and A Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/27/2026Q2 2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.41$1.49+$0.08$1.20$1.80 billion$1.84 billion
5/12/2026Q1 2026
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
-$0.62-$0.33+$0.29-$0.77$21.20 million$20.76 million
4/23/2026Q1 2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$5.25$5.44+$0.19$4.43$10.86 billion$11.01 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.020.75%+6.58%20.48%9 Years
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
N/AN/AN/AN/AN/A
Defiance Daily Target 2X Long LMND ETF stock logo
LMNX
Defiance Daily Target 2X Long LMND ETF
$0.403.49%N/A78.43%N/A
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$1.880.38%+14.34%10.34%8 Years

Latest HBIO, LMNX, TMO, and A Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/20/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
quarterly$0.25500.9%6/30/20266/30/20267/22/2026
5/20/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
quarterly$0.470.42%6/15/20266/15/20267/15/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
0.43
2.10
1.62
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
3.60
1.99
1.06
Defiance Daily Target 2X Long LMND ETF stock logo
LMNX
Defiance Daily Target 2X Long LMND ETF
0.52
8.37
6.08
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.77
1.53
1.15
CompanyEmployeesShares OutstandingFree FloatOptionable
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
18,100282.43 millionN/AOptionable
Harvard Bioscience, Inc. stock logo
HBIO
Harvard Bioscience
4904.51 million3.59 millionOptionable
Defiance Daily Target 2X Long LMND ETF stock logo
LMNX
Defiance Daily Target 2X Long LMND ETF
1,325330,000N/AOptionable
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
125,000371.62 million370.40 millionOptionable

Recent News About These Companies

ICON Stock Valuation vs Peers: Is ICLR Cheap Enough?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Agilent Technologies stock logo

Agilent Technologies NYSE:A

$135.39 +2.70 (+2.04%)
Closing price 06/9/2026 03:59 PM Eastern
Extended Trading
$134.79 -0.60 (-0.44%)
As of 05:29 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Harvard Bioscience stock logo

Harvard Bioscience NASDAQ:HBIO

$6.04 +0.03 (+0.50%)
Closing price 06/9/2026 04:00 PM Eastern
Extended Trading
$5.90 -0.14 (-2.24%)
As of 05:13 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It also provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.

Defiance Daily Target 2X Long LMND ETF stock logo

Defiance Daily Target 2X Long LMND ETF NASDAQ:LMNX

$11.47 +0.27 (+2.41%)
As of 06/9/2026 03:53 PM Eastern

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; and TDAS, an analysis program designed for development and optimization of nucleic acid assays. The company also provides xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism; ARIES system, a sample to answer real-time PCR platform; SYNCT data management software solutions; and ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 Assay, ARIES Flu A/B & RSV Assay, ARIES Group B Streptococcus Assay, ARIES Group A Strep Assay, ARIES Bordetella Assay, ARIES Norovirus Assay, ARIES C. difficile Assay, ARIES MRSA Assay, and SARS-CoV-2 Assay. In addition, it offers VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market; VERIGENE test cartridges; Amnis FlowSight imaging flow cytometers; Amnis ImageStream Mark II imaging flow cytometers; Amnis CellStream for cell and particle analysis; Guava easyCyte benchtop flow cytometers; Muse cell analyzers; and IDEAS, an image analysis software. Luminex Corporation was founded in 1995 and is based in Austin, Texas.

Thermo Fisher Scientific stock logo

Thermo Fisher Scientific NYSE:TMO

$493.91 +24.28 (+5.17%)
Closing price 06/9/2026 03:59 PM Eastern
Extended Trading
$488.30 -5.61 (-1.14%)
As of 05:51 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.